litlas
ログインアカウント作成

James D. Griffin

1979–2025 年に発表

167
論文数
39,995
被引用数
109
h 指数
165
i10 指数

被引用数

James D. Griffin の年別被引用数1975 年: 被引用 1 件1980 年: 被引用 5 件1981 年: 被引用 4 件1982 年: 被引用 11 件1983 年: 被引用 24 件1984 年: 被引用 26 件1985 年: 被引用 28 件1986 年: 被引用 40 件1987 年: 被引用 37 件1988 年: 被引用 36 件1989 年: 被引用 70 件1990 年: 被引用 96 件1991 年: 被引用 128 件1992 年: 被引用 160 件1993 年: 被引用 156 件1994 年: 被引用 157 件1995 年: 被引用 230 件1996 年: 被引用 189 件1997 年: 被引用 200 件1998 年: 被引用 192 件1999 年: 被引用 188 件2000 年: 被引用 200 件2001 年: 被引用 216 件2002 年: 被引用 319 件2003 年: 被引用 418 件2004 年: 被引用 440 件2005 年: 被引用 485 件2006 年: 被引用 492 件2007 年: 被引用 545 件2008 年: 被引用 529 件2009 年: 被引用 464 件2010 年: 被引用 420 件2011 年: 被引用 387 件2012 年: 被引用 382 件2013 年: 被引用 284 件2014 年: 被引用 260 件2015 年: 被引用 206 件2016 年: 被引用 210 件2017 年: 被引用 218 件2018 年: 被引用 198 件2019 年: 被引用 674 件2020 年: 被引用 677 件2021 年: 被引用 607 件2022 年: 被引用 457 件2023 年: 被引用 252 件2024 年: 被引用 434 件2025 年: 被引用 180 件2026 年: 被引用 4 件1976〜1979 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 5,250 件、この内訳の 39.3%ドイツ: 引用元論文 873 件、この内訳の 6.5%イギリス: 引用元論文 845 件、この内訳の 6.3%中国: 引用元論文 778 件、この内訳の 5.8%イタリア: 引用元論文 580 件、この内訳の 4.4%フランス: 引用元論文 538 件、この内訳の 4%日本: 引用元論文 460 件、この内訳の 3.5%カナダ: 引用元論文 439 件、この内訳の 3.3%スイス: 引用元論文 373 件、この内訳の 2.8%オーストラリア: 引用元論文 315 件、この内訳の 2.4%オランダ: 引用元論文 273 件、この内訳の 2%スペイン: 引用元論文 225 件、この内訳の 1.7%
0%39.3%その他 18%

機関

分野

  • Medicine63%
  • Biochemistry, Genetics and Molecular Biology27.1%
  • Immunology and Microbiology5.9%
  • Neuroscience1.1%
  • Chemistry0.8%
  • Computer Science0.7%
  • その他1.4%

トピック

  • Chronic Myeloid Leukemia Treatments6.5%
  • Acute Myeloid Leukemia Research5.4%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment3.5%
  • Eosinophilic Disorders and Syndromes3.1%
  • Chronic Lymphocytic Leukemia Research3%
  • Ubiquitin and proteasome pathways2.3%
  • その他76.2%

共著者

全論文

検索で開く
  1. A Chemoproteomic Approach to Query the Degradable Kinome Using a Multi-kinase Degrader

    著者: Hai‐Tsang Huang, Dennis Dobrovolsky, Joshiawa Paulk, Guang Yang, Ellen Weisberg, Zainab M. Doctor, Dennis L. Buckley, Joong-Heui Cho, Eunhwa Ko, Jaebong Jang, Kun Shi, Hwan Geun Choi, James D. Griffin, Ying Li, Steven P. Treon, Eric S. Fischer, James E. Bradner, Li Tan, Nathanael S. Gray - Cell chemical biology 2017 被引用: 441

  2. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

    著者: Ross L. Levine, Martha Wadleigh, Jan Cools, Benjamin L. Ebert, Gerlinde Wernig, Brian J.P. Huntly, Titus J. Boggon, Iwona Włodarska, Jennifer Clark, Sandra Moore, Jennifer Adelsperger, Sumin Koo, Jeffrey C. Lee, Stacey Gabriel, Thomas Mercher, Alan D. D’Andrea, Stefan Fröhling, Konstanze Döhner, Peter Marynen, Peter Vandenberghe, Ruben A. Mesa, Ayalew Tefferi, James D. Griffin, Michael J. Eck, William R. Sellers, Matthew Meyerson, Todd R. Golub, Stephanie J. Lee, D. Gary Gilliland - Cancer Cell 2005 被引用: 2,991

  3. The roles of FLT3 in hematopoiesis and leukemia

    著者: D. Gary Gilliland, James D. Griffin - Blood 2002 被引用: 1,554

  4. Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl

    著者: Ellen Weisberg, Paul W. Manley, Werner Breitenstein, Josef Brüggen, Sandra W. Cowan‐Jacob, Arghya Ray, Brian J.P. Huntly, Doriano Fabbro, Gabriele Fendrich, Elizabeth Hall–Meyers, Andrew L. Kung, Jürgen Mestan, George Q. Daley, Linda M. Callahan, Laurie Catley, Cara Cavazza, Mohammad Azam, Donna Neuberg, Renee D. Wright, D. Gary Gilliland, James D. Griffin - Cancer Cell 2005 被引用: 1,483

  5. Selective USP7 inhibition elicits cancer cell killing through a p53-dependent mechanism

    著者: Nathan J. Schauer, Xiaoxi Liu, Robert S. Magin, Laura M. Doherty, Wai Cheung Chan, Scott B. Ficarro, Wanyi Hu, Rebekka M. Roberts, Roxana E. Iacob, Björn Stolte, Andrew O. Giacomelli, Sumner Perera, Kyle T. McKay, Sarah A. Boswell, Ellen Weisberg, Arghya Ray, Dharminder Chauhan, Sirano Dhe‐Paganon, Ken C Anderson, James D. Griffin, Jianing Li, William C. Hahn, Peter K. Sorger, John R. Engen, Kimberly Stegmaier, Jarrod A. Marto, Sara J. Buhrlage - Scientific Reports 2020 被引用: 123

  6. Inhibition of USP10 induces degradation of oncogenic FLT3

    著者: Ellen Weisberg, Nathan J. Schauer, Jing Yang, Ilaria Lamberto, Laura M. Doherty, Shruti Bhatt, Atsushi Nonami, Chengcheng Meng, Anthony Letai, Renee D. Wright, Hong L. Tiv, Prafulla C. Gokhale, Maria Stella Ritorto, Virginia De Cesare, Matthias Trost, Alexandra Christodoulou, Amanda L. Christie, David M. Weinstock, Sophia Adamia, Richard M. Stone, Dharminder Chauhan, Kenneth C. Anderson, Hyuk‐Soo Seo, Sirano Dhe‐Paganon, Martin Sattler, Nathanael S. Gray, James D. Griffin, Sara J. Buhrlage - Nature Chemical Biology 2017 被引用: 152

  7. PDGFRs are critical for PI3K/Akt activation and negatively regulated by mTOR

    著者: Hongbing Zhang, Natalia Bajraszewski, Erxi Wu, Hongwei Wang, Annie P. Moseman, Sandra L. Dabora, James D. Griffin, David J. Kwiatkowski - Journal of Clinical Investigation 2007 被引用: 383

  8. BRD9 degraders as chemosensitizers in acute leukemia and multiple myeloma

    著者: Ellen Weisberg, Basudev Chowdhury, Chengcheng Meng, Abigail E. Case, Wei Ni, Swati Garg, Martin Sattler, Abdel Kareem Azab, Jennifer Sun, Barbara Muz, Dana Sanchez, Anthia A. Toure, Richard M. Stone, Ilene Galinsky, Eric S. Winer, Scott Gleim, Sofia Gkountela, Alexia T. Kedves, Edmund Harrington, Tinya J. Abrams, Thomas Zöller, Andrea Vaupel, Paul W. Manley, Michael Faller, BoYee Chung, Xin Chen, Philipp Busenhart, Christine Stephan, Keith Calkins, Débora Bonenfant, Claudio R. Thoma, William C. Forrester, James D. Griffin - Blood Cancer Journal 2022 被引用: 44

  9. The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice

    著者: Elizabeth C. Townsend, Mark A. Murakami, Alexandra Christodoulou, Amanda L. Christie, Johannes Köster, Tiffany DeSouza, Elizabeth A. Morgan, Scott P. Kallgren, Huiyun Liu, Shuo-Chieh Wu, Olivia D. Plana, Joan Montero, Kristen E. Stevenson, Prakash K. Rao, Raga Vadhi, Michael Andreeff, Philippe Armand, Karen K. Ballen, Patrizia Barzaghi-Rinaudo, Sarah Cahill, Rachael A. Clark, Vesselina G. Cooke, Matthew S. Davids, Daniel J. DeAngelo, David M. Dorfman, Hilary Eaton, Benjamin L. Ebert, Julia Etchin, Brant Firestone, David C. Fisher, Arnold S. Freedman, Ilene Galinsky, Hui Gao, Jacqueline S. Garcia, Francine Garnache‐Ottou, Timothy A. Graubert, Alejandro Gutiérrez, Ensar Halilovic, Marian H. Harris, Zachary T. Herbert, Steven M. Horwitz, Giorgio Inghirami, Andrew M. Intlekofer, Moriko Ito, Shai Izraeli, Eric D. Jacobsen, Caron A. Jacobson, Sébastien Jeay, Irmela Jeremias, Michelle A. Kelliher, Raphael Koch, Marina Konopleva, Nadja Kopp, Steven M. Kornblau, Andrew L. Kung, Thomas S. Kupper, Nicole R. LeBoeuf, Ann S. LaCasce, Emma Lees, Loretta S. Li, A. Thomas Look, Masato Murakami, Markus Müschen, Donna Neuberg, Samuel Y. Ng, Oreofe O. Odejide, Stuart H. Orkin, Rachel R. Paquette, Andrew E. Place, Justine E. Roderick, Jeremy Ryan, Stephen E. Sallan, Brent Shoji, Lewis B. Silverman, Robert J. Soiffer, David P. Steensma, Kimberly Stegmaier, Richard M. Stone, Jérôme Tamburini, Aaron R. Thorner, Paul Van Hummelen, Martha Wadleigh, Marion Wiesmann, Andrew P. Weng, Jens Wuerthner, David A. Williams, Bruce M. Wollison, Andrew A. Lane, Anthony Letai, Monica M. Bertagnolli, Jerome Ritz, Myles Brown, Henry W. Long, Jon C. Aster, Margaret A. Shipp, James D. Griffin, David M. Weinstock - Cancer Cell 2016 被引用: 304

  10. A Tyrosine Kinase Created by Fusion of the PDGFRA and FIP1L1 Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic Syndrome

    著者: Jan Cools, Daniel J. DeAngelo, Jason Gotlib, Elizabeth H. Stover, Robert D. Legare, Jörge E. Cortes, Jeffrey L. Kutok, Jennifer Clark, Ilene Galinsky, James D. Griffin, Nicholas C.P. Cross, Ayalew Tefferi, James Malone, Rafeul Alam, Stanley L. Schrier, Janet Schmid, Michal G. Rose, Peter Vandenberghe, Gregor Verhoef, Marc Boogaerts, Iwona Włodarska, Hagop M. Kantarjian, Peter Marynen, Steven Coutré, Richard M. Stone, D. Gary Gilliland - New England Journal of Medicine 2003 被引用: 1,698

  11. Nilotinib in Imatinib-Resistant CML and Philadelphia Chromosome–Positive ALL

    著者: Hagop M. Kantarjian, Francis J. Giles, Lydia Wunderle, Kapil N. Bhalla, Susan O’Brien, Barbara Waßmann, Chiaki Tanaka, Paul W. Manley, P. Rae, William Mietlowski, Kathy Bochinski, Andreas Hochhaus, James D. Griffin, Dieter Hoelzer, Maher Albitar, Margaret Dugan, Jörge E. Cortes, Leila Alland, Oliver G. Ottmann - New England Journal of Medicine 2006 被引用: 1,345

  12. c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.

    著者: Patrick Chi-Chung, Takashi Kijima, Gautam Maulik, Edward A. Fox, Martin Sattler, James D. Griffin, Bruce E. Johnson, Ravi Salgia - 2003 被引用: 460

  13. Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity

    著者: Douglas W. McMillin, Jake Delmore, Ellen Weisberg, Joseph Negri, David C. Geer, Steffen Klippel, Nicholas Mitsiades, Robert Schlossman, Nikhil C. Munshi, Andrew L. Kung, James D. Griffin, Paul G. Richardson, Kenneth C. Anderson, Constantine S. Mitsiades - Nature Medicine 2010 被引用: 315

  14. AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABL

    著者: Ellen Weisberg, Paul W. Manley, J. Mestan, Sandra W. Cowan‐Jacob, Arghya Ray, James D. Griffin - British Journal of Cancer 2006 被引用: 481

  15. Critical role for Gab2 in transformation by BCR/ABL

    著者: Martin Sattler, M. Golam Mohi, Yuri B. Pride, Laura R Quinnan, Nicole A Malouf, Klaus Podar, Franck Gesbert, Hiromi Iwasaki, Shaoguang Li, Richard A. Van Etten, Haihua Gu, James D. Griffin, Benjamin G. Neel - Cancer Cell 2002 被引用: 360

  16. Dexmedetomidine Infusion During Laparoscopic Bariatric Surgery: The Effect on Recovery Outcome Variables

    著者: Burcu Tufanogullari, Paul F. White, Mariana P. Peixoto, Daniel Kianpour, Thomas Lacour, James D. Griffin, Gary D. Skrivanek, Amy Macaluso, Mary Shah, David A. Provost - Anesthesia & Analgesia 2008 被引用: 346

  17. Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor

    著者: Hyung-Gu Kim, Li Tan, Ellen Weisberg, Feiyang Liu, Peter Canning, Hwan Geun Choi, Scott A. Ezell, Hong Wu, Zheng Zhao, Jinhua Wang, Anna Mandinova, James D. Griffin, Alex N. Bullock, Qingsong Liu, Sam W. Lee, Nathanael S. Gray - ACS Chemical Biology 2013 被引用: 147

  18. t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway

    著者: Giovanni Tonon, Sanjay Modi, Lizi Wu, Akihito Kubo, Amy Coxon, Takefumi Komiya, Kevin O’Neil, Kristen Stover, Adel K. El‐Naggar, James D. Griffin, Ilan R. Kirsch, Frederic J. Kaye - Nature Genetics 2003 被引用: 569

  19. The CRTC1-MAML2 fusion is the major oncogenic driver in mucoepidermoid carcinoma

    著者: Zirong Chen, Wei Ni, Jian‐Liang Li, Shuibin Lin, Xin Zhou, Yuping Sun, Jennifer W. Li, Marino E. Leon, Maria D. Hurtado, Sergei Zolotukhin, Chen Liu, Jianrong Lu, James D. Griffin, Frederic J. Kaye, Lizi Wu - JCI Insight 2021 被引用: 68

  20. Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412

    著者: Ellen Weisberg, Christina Boulton, Louise Kelly, Paul W. Manley, Doriano Fabbro, Thomas Meyer, D. Gary Gilliland, James D. Griffin - Cancer Cell 2002 被引用: 602

  21. Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia

    著者: Akinori Yoda, Yuka Yoda, Sabina Chiaretti, Michal Bar‐Natan, Kartik Mani, Scott J. Rodig, Nathan West, Yun Xiao, Jennifer R. Brown, Constantine S. Mitsiades, Martin Sattler, Jeffrey L. Kutok, Daniel J. DeAngelo, Martha Wadleigh, Alfonso Piciocchi, Paola Dal Cin, James E. Bradner, James D. Griffin, Kenneth C. Anderson, Richard M. Stone, Jerome Ritz, Robin Foà, Jon C. Aster, David A. Frank, David M. Weinstock - National Academy of Sciences, Proceedings of the National Academy of Sciences 2009 被引用: 340

  22. Small molecule inhibition of deubiquitinating enzyme JOSD1 as a novel targeted therapy for leukemias with mutant JAK2

    著者: Jing Yang, Ellen Weisberg, Xiaoxi Liu, Robert S. Magin, Wai Cheung Chan, Bin Hu, Nathan J. Schauer, Shengzhe Zhang, Ilaria Lamberto, Laura M. Doherty, Chengcheng Meng, Martin Sattler, Lucía Cabal‐Hierro, Eric S. Winer, Richard M. Stone, Jarrod A. Marto, James D. Griffin, Sara J. Buhrlage - Leukemia 2021 被引用: 33

  23. Inhibition of the deubiquitinating enzyme USP47 as a novel targeted therapy for hematologic malignancies expressing mutant EZH2

    著者: Jing Yang, Ellen Weisberg, Shuang Qi, Wei Ni, Husheng Mei, Zuowei Wang, Chengcheng Meng, Shengzhe Zhang, Mingqi Hou, Ziping Qi, Aoli Wang, Yunyun Jiang, Zongru Jiang, Tao Huang, Qingwang Liu, Robert S. Magin, Laura M. Doherty, Wenchao Wang, Jing Liu, Sara J. Buhrlage, Qingsong Liu, James D. Griffin, Qingsong Liu, James D. Griffin - Leukemia 2022 被引用: 19

  24. STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications

    著者: David A. Tuveson, Nicholas A. Willis, Tyler Jacks, James D. Griffin, Samuel Singer, Christopher D.�M. Fletcher, Jonathan A. Fletcher, George D. Demetri - Oncogene 2001 被引用: 699